nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—OPRM1—telencephalic ventricle—brain cancer	0.0398	0.178	CbGeAlD
Remifentanil—OPRD1—ganglion—brain cancer	0.0364	0.163	CbGeAlD
Remifentanil—OPRM1—ganglion—brain cancer	0.0248	0.111	CbGeAlD
Remifentanil—Pericarditis—Procarbazine—brain cancer	0.0223	0.0287	CcSEcCtD
Remifentanil—Cerebral infarction—Carmustine—brain cancer	0.0185	0.0238	CcSEcCtD
Remifentanil—OPRD1—telencephalon—brain cancer	0.014	0.0628	CbGeAlD
Remifentanil—Nystagmus—Procarbazine—brain cancer	0.0135	0.0174	CcSEcCtD
Remifentanil—Haemoptysis—Procarbazine—brain cancer	0.013	0.0168	CcSEcCtD
Remifentanil—Pleural effusion—Procarbazine—brain cancer	0.0126	0.0162	CcSEcCtD
Remifentanil—Disorientation—Lomustine—brain cancer	0.0123	0.0159	CcSEcCtD
Remifentanil—Cerebral ischaemia—Temozolomide—brain cancer	0.0121	0.0155	CcSEcCtD
Remifentanil—Visual disturbance—Lomustine—brain cancer	0.0116	0.015	CcSEcCtD
Remifentanil—Lymphopenia—Temozolomide—brain cancer	0.0114	0.0147	CcSEcCtD
Remifentanil—OPRM1—brainstem—brain cancer	0.0108	0.0483	CbGeAlD
Remifentanil—OPRM1—telencephalon—brain cancer	0.00956	0.0428	CbGeAlD
Remifentanil—Nightmare—Procarbazine—brain cancer	0.00932	0.012	CcSEcCtD
Remifentanil—OPRD1—head—brain cancer	0.00873	0.0391	CbGeAlD
Remifentanil—OPRK1—head—brain cancer	0.00837	0.0375	CbGeAlD
Remifentanil—Renal failure—Lomustine—brain cancer	0.00836	0.0108	CcSEcCtD
Remifentanil—Hepatic function abnormal—Procarbazine—brain cancer	0.00801	0.0103	CcSEcCtD
Remifentanil—OPRD1—central nervous system—brain cancer	0.00797	0.0357	CbGeAlD
Remifentanil—Disorientation—Procarbazine—brain cancer	0.00783	0.0101	CcSEcCtD
Remifentanil—Haemoglobin—Lomustine—brain cancer	0.00767	0.00988	CcSEcCtD
Remifentanil—OPRK1—central nervous system—brain cancer	0.00764	0.0342	CbGeAlD
Remifentanil—Haemorrhage—Lomustine—brain cancer	0.00763	0.00983	CcSEcCtD
Remifentanil—Coagulopathy—Temozolomide—brain cancer	0.00749	0.00965	CcSEcCtD
Remifentanil—OPRK1—cerebellum—brain cancer	0.00747	0.0335	CbGeAlD
Remifentanil—Visual impairment—Lomustine—brain cancer	0.00736	0.00947	CcSEcCtD
Remifentanil—OPRM1—midbrain—brain cancer	0.00687	0.0308	CbGeAlD
Remifentanil—OPRM1—spinal cord—brain cancer	0.0067	0.03	CbGeAlD
Remifentanil—Pulmonary oedema—Hydroxyurea—brain cancer	0.00665	0.00856	CcSEcCtD
Remifentanil—Leukocytosis—Carmustine—brain cancer	0.00642	0.00827	CcSEcCtD
Remifentanil—OPRD1—brain—brain cancer	0.00633	0.0283	CbGeAlD
Remifentanil—Laryngospasm—Etoposide—brain cancer	0.00625	0.00805	CcSEcCtD
Remifentanil—OPRK1—brain—brain cancer	0.00607	0.0272	CbGeAlD
Remifentanil—Disorientation—Hydroxyurea—brain cancer	0.00606	0.0078	CcSEcCtD
Remifentanil—Dysphagia—Procarbazine—brain cancer	0.00605	0.00779	CcSEcCtD
Remifentanil—OPRM1—endocrine gland—brain cancer	0.00603	0.027	CbGeAlD
Remifentanil—OPRM1—head—brain cancer	0.00596	0.0267	CbGeAlD
Remifentanil—Urinary incontinence—Carmustine—brain cancer	0.00583	0.0075	CcSEcCtD
Remifentanil—Urinary incontinence—Temozolomide—brain cancer	0.00563	0.00725	CcSEcCtD
Remifentanil—Apnoea—Etoposide—brain cancer	0.00551	0.00709	CcSEcCtD
Remifentanil—OPRM1—central nervous system—brain cancer	0.00544	0.0244	CbGeAlD
Remifentanil—Pneumonia—Procarbazine—brain cancer	0.00543	0.00699	CcSEcCtD
Remifentanil—Thrombocytopenia—Lomustine—brain cancer	0.00531	0.00684	CcSEcCtD
Remifentanil—Pain—Carboplatin—brain cancer	0.0053	0.00682	CcSEcCtD
Remifentanil—Sweating—Procarbazine—brain cancer	0.00517	0.00666	CcSEcCtD
Remifentanil—Haematuria—Procarbazine—brain cancer	0.00515	0.00663	CcSEcCtD
Remifentanil—Body temperature increased—Carboplatin—brain cancer	0.0049	0.00631	CcSEcCtD
Remifentanil—Haemoglobin—Procarbazine—brain cancer	0.00487	0.00627	CcSEcCtD
Remifentanil—Haemorrhage—Procarbazine—brain cancer	0.00485	0.00624	CcSEcCtD
Remifentanil—Hallucination—Procarbazine—brain cancer	0.00482	0.00621	CcSEcCtD
Remifentanil—Amnesia—Carmustine—brain cancer	0.00466	0.006	CcSEcCtD
Remifentanil—Nasal congestion—Temozolomide—brain cancer	0.00465	0.00598	CcSEcCtD
Remifentanil—Amnesia—Temozolomide—brain cancer	0.00451	0.0058	CcSEcCtD
Remifentanil—Flushing—Procarbazine—brain cancer	0.0045	0.00579	CcSEcCtD
Remifentanil—Dysuria—Hydroxyurea—brain cancer	0.00438	0.00564	CcSEcCtD
Remifentanil—Chills—Procarbazine—brain cancer	0.00435	0.0056	CcSEcCtD
Remifentanil—Arrhythmia—Procarbazine—brain cancer	0.00433	0.00557	CcSEcCtD
Remifentanil—OPRM1—brain—brain cancer	0.00432	0.0193	CbGeAlD
Remifentanil—Body temperature increased—Lomustine—brain cancer	0.00429	0.00552	CcSEcCtD
Remifentanil—Hypokalaemia—Carmustine—brain cancer	0.00399	0.00513	CcSEcCtD
Remifentanil—Tremor—Procarbazine—brain cancer	0.00395	0.00509	CcSEcCtD
Remifentanil—Anaemia—Procarbazine—brain cancer	0.0039	0.00502	CcSEcCtD
Remifentanil—Hypokalaemia—Temozolomide—brain cancer	0.00385	0.00496	CcSEcCtD
Remifentanil—Dysphagia—Carmustine—brain cancer	0.00379	0.00488	CcSEcCtD
Remifentanil—Syncope—Procarbazine—brain cancer	0.00378	0.00487	CcSEcCtD
Remifentanil—Haemoglobin—Hydroxyurea—brain cancer	0.00377	0.00485	CcSEcCtD
Remifentanil—Haemorrhage—Hydroxyurea—brain cancer	0.00375	0.00483	CcSEcCtD
Remifentanil—Hallucination—Hydroxyurea—brain cancer	0.00373	0.0048	CcSEcCtD
Remifentanil—Loss of consciousness—Procarbazine—brain cancer	0.00371	0.00477	CcSEcCtD
Remifentanil—Cough—Procarbazine—brain cancer	0.00368	0.00474	CcSEcCtD
Remifentanil—Dysphagia—Temozolomide—brain cancer	0.00366	0.00471	CcSEcCtD
Remifentanil—Convulsion—Procarbazine—brain cancer	0.00365	0.00471	CcSEcCtD
Remifentanil—Hypertension—Procarbazine—brain cancer	0.00364	0.00469	CcSEcCtD
Remifentanil—Anxiety—Procarbazine—brain cancer	0.00358	0.00461	CcSEcCtD
Remifentanil—Bronchitis—Temozolomide—brain cancer	0.00352	0.00453	CcSEcCtD
Remifentanil—Dry mouth—Procarbazine—brain cancer	0.00351	0.00452	CcSEcCtD
Remifentanil—Confusional state—Procarbazine—brain cancer	0.00347	0.00447	CcSEcCtD
Remifentanil—Vomiting—Lomustine—brain cancer	0.00345	0.00444	CcSEcCtD
Remifentanil—Oedema—Procarbazine—brain cancer	0.00344	0.00443	CcSEcCtD
Remifentanil—Dysuria—Temozolomide—brain cancer	0.00342	0.00441	CcSEcCtD
Remifentanil—Hyperglycaemia—Carmustine—brain cancer	0.00342	0.0044	CcSEcCtD
Remifentanil—Angiopathy—Hydroxyurea—brain cancer	0.0034	0.00438	CcSEcCtD
Remifentanil—Pneumonia—Carmustine—brain cancer	0.0034	0.00437	CcSEcCtD
Remifentanil—Shock—Procarbazine—brain cancer	0.00339	0.00436	CcSEcCtD
Remifentanil—Thrombocytopenia—Procarbazine—brain cancer	0.00337	0.00434	CcSEcCtD
Remifentanil—Chills—Hydroxyurea—brain cancer	0.00336	0.00433	CcSEcCtD
Remifentanil—Tachycardia—Procarbazine—brain cancer	0.00336	0.00433	CcSEcCtD
Remifentanil—Hyperhidrosis—Procarbazine—brain cancer	0.00333	0.00428	CcSEcCtD
Remifentanil—Renal failure—Carmustine—brain cancer	0.00332	0.00427	CcSEcCtD
Remifentanil—Hyperglycaemia—Temozolomide—brain cancer	0.0033	0.00425	CcSEcCtD
Remifentanil—Pneumonia—Temozolomide—brain cancer	0.00328	0.00423	CcSEcCtD
Remifentanil—Erythema—Hydroxyurea—brain cancer	0.00326	0.0042	CcSEcCtD
Remifentanil—Cardiac arrest—Etoposide—brain cancer	0.00322	0.00415	CcSEcCtD
Remifentanil—Nausea—Lomustine—brain cancer	0.00322	0.00415	CcSEcCtD
Remifentanil—Hypotension—Procarbazine—brain cancer	0.00322	0.00414	CcSEcCtD
Remifentanil—Paraesthesia—Procarbazine—brain cancer	0.00309	0.00398	CcSEcCtD
Remifentanil—Somnolence—Procarbazine—brain cancer	0.00306	0.00394	CcSEcCtD
Remifentanil—Haemoglobin—Carmustine—brain cancer	0.00305	0.00392	CcSEcCtD
Remifentanil—Haemorrhage—Carmustine—brain cancer	0.00303	0.0039	CcSEcCtD
Remifentanil—Anaemia—Hydroxyurea—brain cancer	0.00302	0.00388	CcSEcCtD
Remifentanil—Hallucination—Carmustine—brain cancer	0.00302	0.00388	CcSEcCtD
Remifentanil—Haemoglobin—Temozolomide—brain cancer	0.00294	0.00379	CcSEcCtD
Remifentanil—Pain—Procarbazine—brain cancer	0.00294	0.00379	CcSEcCtD
Remifentanil—Constipation—Procarbazine—brain cancer	0.00294	0.00379	CcSEcCtD
Remifentanil—Haemorrhage—Temozolomide—brain cancer	0.00293	0.00377	CcSEcCtD
Remifentanil—Dysphagia—Etoposide—brain cancer	0.00293	0.00377	CcSEcCtD
Remifentanil—Visual impairment—Carmustine—brain cancer	0.00292	0.00376	CcSEcCtD
Remifentanil—Hallucination—Temozolomide—brain cancer	0.00292	0.00375	CcSEcCtD
Remifentanil—Pharyngitis—Temozolomide—brain cancer	0.00291	0.00374	CcSEcCtD
Remifentanil—Bronchospasm—Etoposide—brain cancer	0.00288	0.00371	CcSEcCtD
Remifentanil—Feeling abnormal—Procarbazine—brain cancer	0.00284	0.00365	CcSEcCtD
Remifentanil—Convulsion—Hydroxyurea—brain cancer	0.00283	0.00364	CcSEcCtD
Remifentanil—Visual impairment—Temozolomide—brain cancer	0.00282	0.00363	CcSEcCtD
Remifentanil—Flushing—Carmustine—brain cancer	0.00281	0.00362	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00276	0.00355	CcSEcCtD
Remifentanil—Urticaria—Procarbazine—brain cancer	0.00273	0.00352	CcSEcCtD
Remifentanil—Body temperature increased—Procarbazine—brain cancer	0.00272	0.0035	CcSEcCtD
Remifentanil—Cardiac disorder—Temozolomide—brain cancer	0.00272	0.0035	CcSEcCtD
Remifentanil—Flushing—Temozolomide—brain cancer	0.00272	0.0035	CcSEcCtD
Remifentanil—Arrhythmia—Carmustine—brain cancer	0.00271	0.00349	CcSEcCtD
Remifentanil—Oedema—Hydroxyurea—brain cancer	0.00266	0.00343	CcSEcCtD
Remifentanil—Angiopathy—Temozolomide—brain cancer	0.00266	0.00342	CcSEcCtD
Remifentanil—Immune system disorder—Temozolomide—brain cancer	0.00265	0.00341	CcSEcCtD
Remifentanil—Mediastinal disorder—Temozolomide—brain cancer	0.00264	0.0034	CcSEcCtD
Remifentanil—Erythema—Carmustine—brain cancer	0.00264	0.0034	CcSEcCtD
Remifentanil—Chills—Temozolomide—brain cancer	0.00263	0.00338	CcSEcCtD
Remifentanil—Pneumonia—Etoposide—brain cancer	0.00263	0.00338	CcSEcCtD
Remifentanil—Nervous system disorder—Hydroxyurea—brain cancer	0.00261	0.00336	CcSEcCtD
Remifentanil—Thrombocytopenia—Hydroxyurea—brain cancer	0.00261	0.00336	CcSEcCtD
Remifentanil—Skin disorder—Hydroxyurea—brain cancer	0.00259	0.00333	CcSEcCtD
Remifentanil—Renal failure—Etoposide—brain cancer	0.00257	0.0033	CcSEcCtD
Remifentanil—Erythema—Temozolomide—brain cancer	0.00255	0.00328	CcSEcCtD
Remifentanil—Hypersensitivity—Procarbazine—brain cancer	0.00254	0.00327	CcSEcCtD
Remifentanil—Tremor—Carmustine—brain cancer	0.00247	0.00318	CcSEcCtD
Remifentanil—Anaemia—Carmustine—brain cancer	0.00244	0.00314	CcSEcCtD
Remifentanil—Pruritus—Procarbazine—brain cancer	0.00244	0.00314	CcSEcCtD
Remifentanil—Agitation—Carmustine—brain cancer	0.00243	0.00312	CcSEcCtD
Remifentanil—Tremor—Temozolomide—brain cancer	0.00239	0.00308	CcSEcCtD
Remifentanil—Dyspnoea—Hydroxyurea—brain cancer	0.00238	0.00306	CcSEcCtD
Remifentanil—Somnolence—Hydroxyurea—brain cancer	0.00237	0.00305	CcSEcCtD
Remifentanil—Anaemia—Temozolomide—brain cancer	0.00236	0.00303	CcSEcCtD
Remifentanil—Diarrhoea—Procarbazine—brain cancer	0.00236	0.00303	CcSEcCtD
Remifentanil—Dyspepsia—Hydroxyurea—brain cancer	0.00235	0.00302	CcSEcCtD
Remifentanil—Agitation—Temozolomide—brain cancer	0.00234	0.00302	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.0023	0.00296	CcSEcCtD
Remifentanil—Convulsion—Carmustine—brain cancer	0.00229	0.00294	CcSEcCtD
Remifentanil—Hypertension—Carmustine—brain cancer	0.00228	0.00293	CcSEcCtD
Remifentanil—Pain—Hydroxyurea—brain cancer	0.00228	0.00293	CcSEcCtD
Remifentanil—Constipation—Hydroxyurea—brain cancer	0.00228	0.00293	CcSEcCtD
Remifentanil—Dizziness—Procarbazine—brain cancer	0.00228	0.00293	CcSEcCtD
Remifentanil—Anxiety—Carmustine—brain cancer	0.00224	0.00288	CcSEcCtD
Remifentanil—Cough—Temozolomide—brain cancer	0.00223	0.00287	CcSEcCtD
Remifentanil—Convulsion—Temozolomide—brain cancer	0.00221	0.00284	CcSEcCtD
Remifentanil—Hypertension—Temozolomide—brain cancer	0.0022	0.00283	CcSEcCtD
Remifentanil—Feeling abnormal—Hydroxyurea—brain cancer	0.0022	0.00283	CcSEcCtD
Remifentanil—Vomiting—Procarbazine—brain cancer	0.00219	0.00282	CcSEcCtD
Remifentanil—Cardiac disorder—Etoposide—brain cancer	0.00218	0.0028	CcSEcCtD
Remifentanil—Flushing—Etoposide—brain cancer	0.00218	0.0028	CcSEcCtD
Remifentanil—Confusional state—Carmustine—brain cancer	0.00217	0.0028	CcSEcCtD
Remifentanil—Rash—Procarbazine—brain cancer	0.00217	0.00279	CcSEcCtD
Remifentanil—Dermatitis—Procarbazine—brain cancer	0.00217	0.00279	CcSEcCtD
Remifentanil—Anxiety—Temozolomide—brain cancer	0.00216	0.00279	CcSEcCtD
Remifentanil—Headache—Procarbazine—brain cancer	0.00216	0.00278	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00216	0.00278	CcSEcCtD
Remifentanil—Oedema—Carmustine—brain cancer	0.00215	0.00277	CcSEcCtD
Remifentanil—Angiopathy—Etoposide—brain cancer	0.00213	0.00274	CcSEcCtD
Remifentanil—Dry mouth—Temozolomide—brain cancer	0.00212	0.00273	CcSEcCtD
Remifentanil—Immune system disorder—Etoposide—brain cancer	0.00212	0.00273	CcSEcCtD
Remifentanil—Mediastinal disorder—Etoposide—brain cancer	0.00211	0.00272	CcSEcCtD
Remifentanil—Thrombocytopenia—Carmustine—brain cancer	0.00211	0.00271	CcSEcCtD
Remifentanil—Body temperature increased—Hydroxyurea—brain cancer	0.00211	0.00271	CcSEcCtD
Remifentanil—Chills—Etoposide—brain cancer	0.0021	0.00271	CcSEcCtD
Remifentanil—Tachycardia—Carmustine—brain cancer	0.0021	0.00271	CcSEcCtD
Remifentanil—Confusional state—Temozolomide—brain cancer	0.0021	0.0027	CcSEcCtD
Remifentanil—Anaphylactic shock—Temozolomide—brain cancer	0.00208	0.00268	CcSEcCtD
Remifentanil—Oedema—Temozolomide—brain cancer	0.00208	0.00268	CcSEcCtD
Remifentanil—Nausea—Procarbazine—brain cancer	0.00204	0.00263	CcSEcCtD
Remifentanil—Nervous system disorder—Temozolomide—brain cancer	0.00204	0.00263	CcSEcCtD
Remifentanil—Thrombocytopenia—Temozolomide—brain cancer	0.00204	0.00262	CcSEcCtD
Remifentanil—Skin disorder—Temozolomide—brain cancer	0.00202	0.0026	CcSEcCtD
Remifentanil—Hypotension—Carmustine—brain cancer	0.00201	0.00259	CcSEcCtD
Remifentanil—Hyperhidrosis—Temozolomide—brain cancer	0.00201	0.00259	CcSEcCtD
Remifentanil—Hypersensitivity—Hydroxyurea—brain cancer	0.00196	0.00253	CcSEcCtD
Remifentanil—Paraesthesia—Carmustine—brain cancer	0.00193	0.00249	CcSEcCtD
Remifentanil—Dyspnoea—Carmustine—brain cancer	0.00192	0.00247	CcSEcCtD
Remifentanil—Somnolence—Carmustine—brain cancer	0.00191	0.00247	CcSEcCtD
Remifentanil—Anaemia—Etoposide—brain cancer	0.00189	0.00243	CcSEcCtD
Remifentanil—Paraesthesia—Temozolomide—brain cancer	0.00187	0.00241	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Carmustine—brain cancer	0.00186	0.00239	CcSEcCtD
Remifentanil—Dyspnoea—Temozolomide—brain cancer	0.00186	0.00239	CcSEcCtD
Remifentanil—Somnolence—Temozolomide—brain cancer	0.00185	0.00238	CcSEcCtD
Remifentanil—Constipation—Carmustine—brain cancer	0.00184	0.00237	CcSEcCtD
Remifentanil—Pain—Carmustine—brain cancer	0.00184	0.00237	CcSEcCtD
Remifentanil—Dyspepsia—Temozolomide—brain cancer	0.00183	0.00236	CcSEcCtD
Remifentanil—Diarrhoea—Hydroxyurea—brain cancer	0.00182	0.00235	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Temozolomide—brain cancer	0.0018	0.00231	CcSEcCtD
Remifentanil—Loss of consciousness—Etoposide—brain cancer	0.00179	0.00231	CcSEcCtD
Remifentanil—Cough—Etoposide—brain cancer	0.00178	0.00229	CcSEcCtD
Remifentanil—Pain—Temozolomide—brain cancer	0.00178	0.00229	CcSEcCtD
Remifentanil—Constipation—Temozolomide—brain cancer	0.00178	0.00229	CcSEcCtD
Remifentanil—Feeling abnormal—Carmustine—brain cancer	0.00177	0.00228	CcSEcCtD
Remifentanil—Convulsion—Etoposide—brain cancer	0.00177	0.00228	CcSEcCtD
Remifentanil—Hypertension—Etoposide—brain cancer	0.00176	0.00227	CcSEcCtD
Remifentanil—Dizziness—Hydroxyurea—brain cancer	0.00176	0.00227	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00173	0.00222	CcSEcCtD
Remifentanil—Feeling abnormal—Temozolomide—brain cancer	0.00172	0.00221	CcSEcCtD
Remifentanil—Body temperature increased—Carmustine—brain cancer	0.0017	0.00219	CcSEcCtD
Remifentanil—Vomiting—Hydroxyurea—brain cancer	0.00169	0.00218	CcSEcCtD
Remifentanil—Rash—Hydroxyurea—brain cancer	0.00168	0.00216	CcSEcCtD
Remifentanil—Confusional state—Etoposide—brain cancer	0.00168	0.00216	CcSEcCtD
Remifentanil—Dermatitis—Hydroxyurea—brain cancer	0.00168	0.00216	CcSEcCtD
Remifentanil—Headache—Hydroxyurea—brain cancer	0.00167	0.00215	CcSEcCtD
Remifentanil—Anaphylactic shock—Etoposide—brain cancer	0.00167	0.00214	CcSEcCtD
Remifentanil—Urticaria—Temozolomide—brain cancer	0.00165	0.00213	CcSEcCtD
Remifentanil—Body temperature increased—Temozolomide—brain cancer	0.00165	0.00212	CcSEcCtD
Remifentanil—Thrombocytopenia—Etoposide—brain cancer	0.00163	0.0021	CcSEcCtD
Remifentanil—Tachycardia—Etoposide—brain cancer	0.00163	0.00209	CcSEcCtD
Remifentanil—Skin disorder—Etoposide—brain cancer	0.00162	0.00208	CcSEcCtD
Remifentanil—Hyperhidrosis—Etoposide—brain cancer	0.00161	0.00207	CcSEcCtD
Remifentanil—Hypersensitivity—Carmustine—brain cancer	0.00159	0.00204	CcSEcCtD
Remifentanil—Nausea—Hydroxyurea—brain cancer	0.00158	0.00204	CcSEcCtD
Remifentanil—Hypotension—Etoposide—brain cancer	0.00156	0.002	CcSEcCtD
Remifentanil—Hypersensitivity—Temozolomide—brain cancer	0.00153	0.00197	CcSEcCtD
Remifentanil—Paraesthesia—Etoposide—brain cancer	0.0015	0.00193	CcSEcCtD
Remifentanil—Dyspnoea—Etoposide—brain cancer	0.00148	0.00191	CcSEcCtD
Remifentanil—Somnolence—Etoposide—brain cancer	0.00148	0.00191	CcSEcCtD
Remifentanil—Diarrhoea—Carmustine—brain cancer	0.00147	0.0019	CcSEcCtD
Remifentanil—Pruritus—Temozolomide—brain cancer	0.00147	0.0019	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Etoposide—brain cancer	0.00144	0.00185	CcSEcCtD
Remifentanil—Dizziness—Carmustine—brain cancer	0.00142	0.00183	CcSEcCtD
Remifentanil—Pain—Etoposide—brain cancer	0.00142	0.00183	CcSEcCtD
Remifentanil—Constipation—Etoposide—brain cancer	0.00142	0.00183	CcSEcCtD
Remifentanil—Diarrhoea—Temozolomide—brain cancer	0.00142	0.00183	CcSEcCtD
Remifentanil—Dizziness—Temozolomide—brain cancer	0.00138	0.00177	CcSEcCtD
Remifentanil—Feeling abnormal—Etoposide—brain cancer	0.00137	0.00177	CcSEcCtD
Remifentanil—Vomiting—Carmustine—brain cancer	0.00137	0.00176	CcSEcCtD
Remifentanil—Rash—Carmustine—brain cancer	0.00136	0.00175	CcSEcCtD
Remifentanil—Dermatitis—Carmustine—brain cancer	0.00136	0.00175	CcSEcCtD
Remifentanil—Headache—Carmustine—brain cancer	0.00135	0.00174	CcSEcCtD
Remifentanil—Vomiting—Temozolomide—brain cancer	0.00132	0.0017	CcSEcCtD
Remifentanil—Urticaria—Etoposide—brain cancer	0.00132	0.0017	CcSEcCtD
Remifentanil—Body temperature increased—Etoposide—brain cancer	0.00132	0.0017	CcSEcCtD
Remifentanil—Rash—Temozolomide—brain cancer	0.00131	0.00169	CcSEcCtD
Remifentanil—Dermatitis—Temozolomide—brain cancer	0.00131	0.00169	CcSEcCtD
Remifentanil—Headache—Temozolomide—brain cancer	0.0013	0.00168	CcSEcCtD
Remifentanil—Nausea—Carmustine—brain cancer	0.00128	0.00165	CcSEcCtD
Remifentanil—Nausea—Temozolomide—brain cancer	0.00124	0.00159	CcSEcCtD
Remifentanil—Hypersensitivity—Etoposide—brain cancer	0.00123	0.00158	CcSEcCtD
Remifentanil—Pruritus—Etoposide—brain cancer	0.00118	0.00152	CcSEcCtD
Remifentanil—Diarrhoea—Etoposide—brain cancer	0.00114	0.00147	CcSEcCtD
Remifentanil—Dizziness—Etoposide—brain cancer	0.0011	0.00142	CcSEcCtD
Remifentanil—Vomiting—Etoposide—brain cancer	0.00106	0.00136	CcSEcCtD
Remifentanil—Rash—Etoposide—brain cancer	0.00105	0.00135	CcSEcCtD
Remifentanil—Dermatitis—Etoposide—brain cancer	0.00105	0.00135	CcSEcCtD
Remifentanil—Headache—Etoposide—brain cancer	0.00104	0.00134	CcSEcCtD
Remifentanil—Nausea—Etoposide—brain cancer	0.000989	0.00127	CcSEcCtD
